Tag archive for ‘Pharma acquisition news’
Roivant Sciences inks $7.3bn merger deal with Montes Archimedes Acquisition
By businessnewstoday On Tuesday, May 4th, 2021
0 Comments

Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition

(adsbygoogle = window.adsbygoogle || []).push({}); Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that More...

MGC Pharmaceuticals to acquire Israeli clinical and medical research firm MediCaNL
By businessnewstoday On Thursday, April 22nd, 2021
0 Comments

MGC Pharma to acquire clinical and medical research firm MediCaNL

MGC Pharmaceuticals (MGC Pharma), a bio-pharma company focused on phytocannabinoid-derived medicines, has acquired MediCaNL, the owner of Israeli clinical and medical research company MediCaNL Israel 2019, for AUD6 More...

Thermo Fisher to acquire clinical research services provider PPD for $21bn
By businessnewstoday On Friday, April 16th, 2021
0 Comments

Thermo Fisher to acquire clinical research services provider PPD for $21bn

Thermo Fisher Scientific has agreed to acquire PPD, a US-based clinical research services provider, for $47.50 per share or $20.9 billion. The consideration includes assumption of nearly $3.5 billion of the contract More...

Merck wraps up $1.8bn acquisition of Pandion Therapeutics
By businessnewstoday On Sunday, April 11th, 2021
0 Comments

Merck wraps up $1.8bn acquisition of Pandion Therapeutics

Merck has wrapped up its previously announced $1.85 billion acquisition of Massachusetts-based clinical-stage biotech company Pandion Therapeutics. The pharma giant said that it had successfully completed the cash More...

Amgen acquisition of Rodeo Therapeutics
By businessnewstoday On Wednesday, March 31st, 2021
0 Comments

Amgen to acquire Rodeo Therapeutics in $721m worth deal

Amgen has agreed to acquire Rodeo Therapeutics, a Seattle-based biopharma company, in a deal worth up to $721 million. Rodeo Therapeutics is engaged in developing small-molecule therapies designed for promoting More...

Amgen acquisition of Five Prime Therapeutics
By businessnewstoday On Thursday, March 4th, 2021
0 Comments

Amgen to acquire Five Prime Therapeutics for gastric cancer candidate bemarituzumab

Amgen acquisition of Five Prime Therapeutics : Amgen has agreed to acquire Five Prime Therapeutics, a clinical-stage biotech company, for about $1.9 billion, to add a phase 3 ready gastric cancer candidate called More...

Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn
By businessnewstoday On Tuesday, March 2nd, 2021
0 Comments

Altaris Capital Partners to acquire Perrigo Rx business for $1.5bn

Altaris Capital Partners has agreed to acquire the prescription pharma (Rx) business of Perrigo Company plc, an Ireland-based pharma company, for about $1.55 billion. The Rx business of Perrigo employs over 1,300 More...

Roivant Sciences acquisition of Silicon Therapeutics
By businessnewstoday On Friday, February 26th, 2021
0 Comments

Roivant Sciences to acquire Silicon Therapeutics to boost drug discovery capabilities

Roivant Sciences has agreed to acquire Silicon Therapeutics, a Boston-based drug design, research, and development company, for $450 million, in an all-share deal. The Swiss biopharma company will also make additional More...

Merck acquisition of Pandion Therapeutics
By businessnewstoday On Thursday, February 25th, 2021
0 Comments

Merck to acquire US biotech company Pandion Therapeutics for $1.8bn

Merck has agreed to acquire Pandion Therapeutics, a Massachusetts-based clinical-stage biotech company, for about $1.85 billion in an all-cash deal. Pandion Therapeutics is engaged in developing therapeutics for More...

Eurofins Scientific to acquire Beacon Discovery to expand drug discovery capabilities
By businessnewstoday On Thursday, February 18th, 2021
0 Comments

Eurofins Scientific to acquire Beacon Discovery to expand drug discovery capabilities

Eurofins Scientific, a testing laboratories company based in Luxembourg, has agreed to acquire Beacon Discovery, a drug discovery and contract research organization (CRO), engaged in the research of G-Protein Coupled More...